.jpg "Joel Tarning, PhD photo")
Professor of Clinical Pharmacology
University of Oxford
Professor Joel Tarning, PhD, started his scientific research in 2007 at the Mahidol-Oxford Tropical Medicine Research Unit (MORU) in Bangkok, Thailand. He was conferred the title Professor of Clinical Pharmacology at the University of Oxford, UK in 2016. He leads a large and diverse team of 30 people studying clinical pharmacology and the main scientific directions within the department are pharmacometric data analysis, bioanalytical method development, drug quantification of clinical study samples, omics-based research and medicine quality. His main research is focused on antimalarial dose-optimisation in vulnerable populations at risk of treatment failure and resistance development, such as children and pregnant women. His work on population pharmacokinetic-pharmacodynamic modelling of antimalarial drugs resulted in revised WHO dosing guidelines in 2015.
Professor Tarning has published over 160 peer-reviewed articles in international journals, mostly focusing on the clinical pharmacology of antimalarial drugs. Among these articles are numerous high-impact papers in journals such as New England Journal of Medicine, Lancet Infectious Diseases and PLOS Medicine, resulting in a total of 9,930 citations. He is a member of the editorial board of CPT: Pharmacometrics & Systems, Antimicrobial Agents and Chemotherapy and International Journal of Pharmacokinetics.
Professor Tarning has been an external expert for the World Health Organisation on several different review groups since 2008, and was part of writing the latest edition of the antimalarial dosing guidelines (2015). His work on clinical pharmacology of antimalarial drugs have already made an impact on public health and he was awarded the biennial Giorgio Segré Prize from the European Federation for Pharmaceutical Sciences in 2014, the annual Bailey K. Ashford Medal from the American Society for Tropical Medicine and Hygiene in 2019, and the biennial Grahame-Smith Prize from the British Pharmacological Society in 2020 for his research.
Disclosure information not submitted.
Thursday, January 13, 2022
9:00 PM – 10:00 PM ET
.png)